Plasma methoxytyramine: A novel biomarker of metastatic pheochromocytoma and paraganglioma in relation to established risk factors of tumour size, location and SDHB mutation status

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

European Journal of Cancer

Topics

Biochemistry

Cancer Oncology

Pathology

Internal Medicine

Endocrinology

Surgery

Biology

Biochemistry

Medicine

Cancer Oncology

Pathology

Show all topics

DOI

10.1016/j.ejca.2011.07.016

Other Formats

PDF